Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Construction Press Releases.
Press releases published on September 2, 2025
Zscaler Reports Fourth Quarter and Fiscal 2025 Financial Results
GlobeNewswire
·
September 2, 2025
Fourth Quarter Highlights Revenue grows 21% year-over-year to $719.2 million Annual Recurring Revenue ("ARR") grows 22% year-over-year to $3,015 million Calculated billings grows 32% year-over-year to $1,202.3 million Deferred revenue grows 30% year-over- …
The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos
GlobeNewswire
·
September 2, 2025
CERRITOS, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, today announced the launch of its Lung Cancer Center of Excellence in Fort Lauderdale, Florida. The …
Rackspace Technology Names Gajen Kandiah Chief Executive Officer
GlobeNewswire
·
September 2, 2025
SAN ANTONIO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a global provider of hybrid cloud and AI solutions, today announced that its Board of Directors has appointed Gajen Kandiah as Chief Executive Officer, effective September …
Lyell Immunopharma Announces Participation in September Investor Conferences
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing next-generation CAR T-cell therapies for patients with cancer, …
Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 2, 2025
FRAMINGHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and Chief …
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
GlobeNewswire
·
September 2, 2025
WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial …
HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results
GlobeNewswire
·
September 2, 2025
Highlights of the second quarter include: Revenue of $325.8 million, an increase of 9% compared to $299.9 million in Q2 FY25. Net income of $59.9 million, an increase of 67% compared to $35.8 million in Q2 FY25, with non-GAAP net income of $94.6 million, …
Ascendis to Share Latest Endocrinology Rare Disease Data in 3 Oral Presentations at ASBMR 2025
GlobeNewswire
·
September 2, 2025
COPENHAGEN, Denmark, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced three oral presentations of its latest achondroplasia and hypoparathyroidism data at ASBMR 2025, the annual meeting of the American Society for Bone …
Mineralys Therapeutics Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
September 2, 2025
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …
Cognition Therapeutics Closes $30 Million Registered Direct Offering to Two New Fundamental Institutional Investors, Including a Preeminent Global Investment Firm to Support Phase 3 Development of Zervimesine (CT1812)
GlobeNewswire
·
September 2, 2025
PURCHASE, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, closed its previously announced registered …
Kaleris Honored with ICTSI’s Strategic Supplier Award for Excellence in Partnership
GlobeNewswire
·
September 2, 2025
ATLANTA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kaleris, a global provider of leading supply chain software and optimization solutions, has received the “Strategic Supplier Award” from International Container Terminal Services, Inc. (ICTSI). The award was …
Toll Brothers Announces Bluffs at Granite Highlands Now Open for Sale in Washington State near Portland, Oregon
GlobeNewswire
·
September 2, 2025
WASHOUGAL, Wash., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the opening of Bluffs at Granite Highlands, a new Portland-area community of luxury single-family homes in …
Harms from Modified mRNA COVID-19 Vaccines Discussed in the Journal of American Physicians and Surgeons
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Experience to date indicates that modified mRNA COVID-19 vaccines can disrupt every body system, and that urgent scrutiny and accountability are needed, write Andrew Zywiec, M.D., and others in the fall …
Solintel and Lissol Sign Strategic Joint Venture MoU for Global Intellifos Hub Manufacturing and Market Expansion
EIN Presswire
·
September 2, 2025
Joint venture establishes Portugal as a strategic European hub for worldwide Intellifos Hub deployment TALLINN, ESTONIA, September 2, 2025 /EINPresswire.com/ -- Solintel OU, a leading developer of advanced Intellifos Hub technology, and Lissol – Lithium …
Centralised Platform Launched to Connect Businesses with Facilities Management Providers Across the UK
EIN Presswire
·
September 2, 2025
LONDON, UNITED KINGDOM, September 2, 2025 /EINPresswire.com/ -- A new digital platform has been launched in the United Kingdom to serve as a central hub for the facilities management (FM) industry, connecting service providers with businesses seeking …
The Implications of Artificial Intelligence (AI) for Medicine Discussed in the Journal of American Physicians and Surgeons
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) is envisioned by many to be the future of medicine, and it is critical to understand its implications and the background of technocracy, which AI will serve, writes Patrick Wood …
Medidata Secures a Leader Position in Everest Group’s PEAK Matrix® Assessment for eCOA, Driving the New Patient Experience Forward
GlobeNewswire
·
September 2, 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group‘s Life Sciences Electronic Clinical Outcome …
Evidence for ‘Chemtrails’ Examined in the Journal of American Physicians and Surgeons
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The “chemtrails” theory gained prominence in the Make America Healthy Again (MAHA) movement, leading to the enactment of related legislative measures. In the fall issue of the Journal of American Physicians …